Navigation Links
UCB Becomes Pinnacle Donor to the American College of Rheumatology Research and Education Foundation's Research Campaign
Date:10/27/2008

e for future generations," said Hellebo. "Our goal is to help patients living with RA get to better days fast and the research that comes from this donation will help us achieve that goal."

Rheumatoid arthritis (RA) is a progressive autoimmune disease that causes chronic inflammation of the joints. It is estimated that five million people suffer from RA globally. Symptoms of RA include joint stiffness, joint pain, inflammation of the affected areas and an associated reduction in mobility and can eventually lead to disability. RA patients are also at a higher risk of developing other conditions, in particular heart disease, stroke, infections, lung problems and osteoporosis.

About Within Our Reach: Finding a Cure for Rheumatoid Arthritis

Rheumatoid arthritis affects an estimated 1.3 million Americans, yet funding to find new treatments and ultimately a cure remains significantly low compared to other autoimmune diseases. To address the critical need for additional funding and research support, the REF launched Within Our Reach in November 2006.

Within Our Reach is the largest private fundraising campaign in the REF's history. It will tap a diverse donor base, and raise $30 million to accelerate the innovative research necessary to find a cure for RA. The campaign has received tremendous support from the pharmaceutical industry, biotech companies, physicians and patients, raising more than $24 million to date.

To learn more about rheumatoid arthritis and the campaign, please visit http://www.WithinOurReach.info.

About ACR Research and Education Foundation

The ACR Research and Education Foundation was established in 1985 as a 501(c)(3) with a mission to improve patients' lives through support of research and training that advances the prevention, treatment and cure of rheumatic diseases. Since its founding, the REF has promoted and advanced the field of rheumatol
'/>"/>

SOURCE UCB
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. MRI finds breast cancer before it becomes dangerous
2. MinuteClinic Becomes Participating Provider with Assurant Health
3. Neusoft Becomes First Global Growth Company Partner of World Economic Forum
4. Michael Moores SiCKO Becomes the Third Highest Grossing Documentary of All Time Surpassing An Inconvenient Truth
5. SMART Association Becomes Healthcare Council Member of Smart Card Alliance
6. Smurfit-Stones Hodge, LA, Mill Becomes First to Achieve Safety Milestone
7. Dr. Dan L. Fortenbacher, O.D., FCOVD, Becomes 29th President of College of Optometrists in Vision Development (COVD); Unveils 7-Part Development Plan for Ongoing Growth
8. PharmMD Becomes an ASCP MTM Provider Partner
9. Outcomes Pharmaceutical Health Care(r) Becomes an ASCP MTM Provider Partner
10. Pharm MD Solutions Becomes an ASCP MTM Provider Partner
11. Wal-Mart Becomes One of the First to Offer Over-the-Counter Zyrtec

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...ISCO,Nov.25/PRNewswire/--TheBayAreaAirQualityManag...pare the Air Alert forThursday,November...anyothersolidfuel,bothindoorsandoutdoors. ,, "C...ytomorrow,"saidJackBroadbent,executiveofficerofthe...hehealthoftheirneighborsandfellowcommunitymemberst...
(Date:11/25/2009)...ivors of testicular cancer who were treated with c...ffects, including neurological side effects and Ra...d with chemotherapy, according to a new study publ...tional Cancer Institute . , Marianne Brydy, M.D....ity Hospital, in Bergen, Norway, and colleagues co...
(Date:11/25/2009)... discovery that grew out of a collaboration betwee...offer hope to the nearly 10 million Americans who ...lso known as hardening of the arteries, peripheral... problem in which narrowed arteries reduce blood f...d flag for vascular disease, heart attack and stro...
(Date:11/25/2009)...-up period was too short to draw definite conclusi...5 (HealthDay News) -- In diabetic patients with bl...fference in outcomes at one year whether patients ...g, British researchers report. , Bypass surgery...ents with coronary artery disease. However, less i...
(Date:11/25/2009)... Evaluation and treatment clinics to resu...stock (Vocus) November 25, 2009 -- Centegra Health... and H1N1 vaccine shots at four Centegra Primary C...nt of vaccine has arrived. The clinics are at CPC ...nry and will be open as follows: ,   F...
Breaking Medicine News(10 mins):Health News:Winter Spare the Air Alert in Effect for Thursday, November 26, 2009 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 4Health News:Stenting May Equal Bypass for Diabetic Heart Patients 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 4
... BARCELONA, SPAIN, September 25, 2007 In clinica...lung cancer (NSCLC) that are classified as having ...nificant higher survival when treated in the secon...t # 6521) were presented at the 14th European Can...
...tient received stolen piece of bone during neck su...exas man has filed a,lawsuit against the billion-d...YSE: MDT ) for fraud and negligence in a "body-sn...eme Court of the State of New York also names as d...
...W YORK, Sept. 26 The American Liver Foundation (A...search and improving the,quality of life for the 3...today that Rick Smith has been named to become the...ience leading prominent,national health organizati...
... Barcelona, Spain: In a surprising finding, Americ...ageal cancer, married patients dont fare as well a...their quality of life. , In the study, presented..., a non-cancerous condition linked to acid reflux,...
...USTON, Sept. 26 US Med-Equip, an industry leader ...rvice and smarts to acute,care and homecare provid...Houston, Texas. This expansion into a state of the...on it for future,plans. The 15,000 square feet of ...
...S ANGELES, Sept. 26 TIGroup, Inc. (OTC,Bulletin B...s provider to,the healthcare industry focused on a...sses designed to deliver quality healthcare servic...company,s board,since 2001. Smith was most recent...
Other Medicine News:Health News:Studies suggest key correlation between lung cancer subtype and treatment outcomes 2Health News:Studies suggest key correlation between lung cancer subtype and treatment outcomes 3Health News:The Law Offices of John David Hart: Texas Man Sues Medtronic in 'Body-Snatching' Case 2Health News:The American Liver Foundation Appoints Rick Smith, a Twenty-Year Veteran of The MS Society, as Chief Executive Officer 2Health News:Married esophageal cancer patients fare worse in some quality of life aspects than single patients 2Health News:US Med-Equip Expands Corporate Support Center 2Health News:TIGroup Names Dennis M. Smith as Chief Financial Officer 2Health News:TIGroup Names Dennis M. Smith as Chief Financial Officer 3Health News:TIGroup Names Dennis M. Smith as Chief Financial Officer 4
(Date:11/25/2009)..., EXTON,Pa.,Nov.25/PRNewswire/--BioTrendsResear...: Stelara report,thefirstinamulti-phasesyndicate...rtho-Biotech,sStelara,fromproductlaunchthroughthef...videsquantitativeinformationfrom75uniqueDermatolog...portsassesstrialanduseofStelara,obstaclestouse,typ...
(Date:11/25/2009)..., WESTPALMBEACH,Fla.,Nov.25/PRNewswire-FirstCal...,especiallythe27millionlivingwithuntreated hearing...istCindyBeyer. ,, Dr.Beyer,seniorvicepresidento...areand hearingaids companies,saidstudieshavelinked...,"whichcaneasilybeintensifiedatholidaygatheringswi...
(Date:11/25/2009)..., RANCHOCORDOVA,Calif.,Nov.25/PRNewswire/--AMPA...cCorporation(Nasdaq: APFC )announcedtodaythatitrec...tyAwardattheAnnualStatewideEnvironmentalSummit,spo...ociation(CMTA),theIndustrialEnvironmentalAssociati...ICC)heldinSanDiego.Thisisthemostprestigiousawardav...
Breaking Medicine Technology:Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2For Millions With Untreated Hearing Loss, Holiday Season Can be Especially Difficult 2AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 2Baking Soda May Be Key Ingredient for Kidney Patients 52007 1Baking Soda May Be Key Ingredient for Kidney Patients 52007 2Omar S Manejwala MD Speaks Out Nationally on Diprivan Propofol Abuse 52002 1Omar S Manejwala MD Speaks Out Nationally on Diprivan Propofol Abuse 52002 2Omar S Manejwala MD Speaks Out Nationally on Diprivan Propofol Abuse 52002 3Omar S Manejwala MD Speaks Out Nationally on Diprivan Propofol Abuse 52002 4Wake Forest Baptist Medical Center Names Chadwick CFO 51998 1Wake Forest Baptist Medical Center Names Chadwick CFO 51998 2
...DA Submission in 2009, SEATTLE, March 25 Cell Th...nced today that enrollment is complete in,the phas... (BBR2278) for,patients with relapsed diffuse larg... of the data is expected in the second half of 200...nd Drug Administration (FDA) the data,could provid...
...if., March 24 NuRx,Pharmaceuticals, Inc. (OTC Bul...e first patient in a Phase I clinical trial of the...X4204., The single-center study, which NuRx expec... is designed to evaluate the safety and tolerabili... drug candidate in clinical,trials., "Our preclin...
Other Medicine Technology:Cell Therapeutics, Inc. (CTI) Announces Enrollment Complete in Phase III EXTEND (PIX301) Clinical Trial of Pixantrone in Patients With Second or Greater Relapse of Diffuse Large B Cell NHL 2Cell Therapeutics, Inc. (CTI) Announces Enrollment Complete in Phase III EXTEND (PIX301) Clinical Trial of Pixantrone in Patients With Second or Greater Relapse of Diffuse Large B Cell NHL 3Cell Therapeutics, Inc. (CTI) Announces Enrollment Complete in Phase III EXTEND (PIX301) Clinical Trial of Pixantrone in Patients With Second or Greater Relapse of Diffuse Large B Cell NHL 4NuRx Pharmaceuticals Doses First Patient in Phase I Clinical Trial of First-in-Class RXR Agonist NRX4204 2
Schuco® 3000 Nebulizer
... developing diverse medical products for more than...ed an outstanding reputation for innovation, quali...ationally recognized brands include the Labtron&re...ical sundry products, Bristoline® microscopes,...
...ntrainment Nebulizers deliver particulate humidity...tion patients. For your convenience, Thera-Mist&re...y of sterile water., ,The P30000N, for normal flo...tal flow range of 68-24 lpm. For your high flow ne...
...er can be held at angles up to 45° without sac...mn, finger grooves for a non-slip gripping surface... of regular oxygen tubing. The large diffuser and...tain optimum mist concentration at every setting. ...
Medicine Products: